NCT04081779

Brief Summary

This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in rural areas often face barriers to survivorship care and report unmet needs. A survivorship care plan created by the patient (self-generated) may help them to better transition from oncology to primary care and improve communication between care teams in order to meet these needs and create better health outcomes. Telehealth is a way of delivering health care services from a distance, including patient education. Combining a self-generated survivorship care plan with telehealth education may help to improve knowledge and self-efficacy in cancer survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
261

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 9, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

February 19, 2020

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

5.9 years

First QC Date

August 29, 2019

Last Update Submit

April 7, 2026

Conditions

Keywords

Cancer survivorssurvivorship care plansprimary care

Outcome Measures

Primary Outcomes (5)

  • Initial participation rate of cancer survivors identified from community-based or partner practices, and Cancer Surveillance System of Western Washington

    Up to 8 weeks

  • Accuracy of survivors' self-generated survivorship care plans (SCPs) in relation to those based on medical record abstraction

    Will measure the accuracy of participants' SCPs by comparing their self-reported medical history collected via questionnaire, with data abstracted from medical records. Accuracy will be reported by percentage of missing data in the self-generated SCP compared to medical records, and percentage of incorrect data in the self-generated SCP compared to medical records.

    Up to 8 weeks

  • Proportion of survivors who receive the phone-based education session within the study time period

    Up to 8 weeks

  • Proportion of survivors who complete the follow-up questionnaire within the study time period

    Up to 8 weeks

  • Response rate among primary care providers (PCPs) to the PCP survey

    Up to 8 weeks

Secondary Outcomes (4)

  • Participant perceived self-efficacy: questionnaire using the PROMIS Global 10 and health related self-efficacy scales

    Up to 8 weeks

  • Survivorship knowledge

    Up to 8 weeks

  • PCP self-efficacy towards survivorship care

    Up to 8 weeks

  • Local oncology clinics' attitudes towards survivorship care implementation

    Up to 8 weeks

Study Arms (5)

Arm I (patient-generated SCP)

ACTIVE COMPARATOR

Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses).

Other: Survivorship Care PlanOther: Questionnaire Administration

Arm II (patient-generated SCP, counseling)

EXPERIMENTAL

Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors.

Other: Survivorship Care PlanOther: Educational InterventionOther: Questionnaire Administration

Arm III (generic information)

ACTIVE COMPARATOR

Patients receive generic information on survivorship care on study.

Other: Questionnaire AdministrationOther: Supportive Care

Arm IV (generic information, patient-generated SCP)

ACTIVE COMPARATOR

Patients receive generic information on survivorship care and a self-generated SCP as in Arm I on study.

Other: Survivorship Care PlanOther: Questionnaire AdministrationOther: Supportive Care

Arm V (generic information, patient-generated SCP, counseling)

EXPERIMENTAL

Patients receive generic information on survivorship care as well as a self-generated SCP as in Arm I and a telephone-based educational counseling session as in Arm II on study.

Other: Survivorship Care PlanOther: Educational InterventionOther: Questionnaire AdministrationOther: Supportive Care

Interventions

Receive patient-generated SCP

Arm I (patient-generated SCP)Arm II (patient-generated SCP, counseling)Arm IV (generic information, patient-generated SCP)Arm V (generic information, patient-generated SCP, counseling)

Receive telephone-based educational counseling session

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Arm II (patient-generated SCP, counseling)Arm V (generic information, patient-generated SCP, counseling)

Ancillary studies

Arm I (patient-generated SCP)Arm II (patient-generated SCP, counseling)Arm III (generic information)Arm IV (generic information, patient-generated SCP)Arm V (generic information, patient-generated SCP, counseling)

Receive generic information on survivorship care

Also known as: Supportive Therapy, Symptom Management
Arm III (generic information)Arm IV (generic information, patient-generated SCP)Arm V (generic information, patient-generated SCP, counseling)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cancer survivors who have completed curative therapy within the past 5 years (may still currently be on long-term/targeted non-cytotoxic agent maintenance therapy, e.g., tamoxifen or aromatase inhibitors for breast cancer survivors; androgen deprivation therapy for prostate cancer survivors)
  • History of either adult-onset (age \>= 18) lymphoma, breast, colorectal, lung, or prostate cancer
  • Able to perform all study requirements, including responding to questionnaires
  • Willing to be randomized
  • Capable of providing informed consent
  • Consent to release oncology and primary care medical records
  • English or Spanish speakers
  • PRIMARY CARE PROVIDERS: PCPs responsible for delivering primary care to IMPACT study participants will be contacted about participating in the study after participant enrollment into the study.
  • ONCOLOGY STAFF: Oncology Staff (Oncologists, Nurse Practitioners, Physician's assistants) will be recruited from sites involved in the IMPACT study
  • CLINIC ADMINISTRATORS: Clinic administrators will be recruited from sites involved in the IMPACT study

You may not qualify if:

  • Currently on palliative or hospice care, or considering transferring to such care within the next 3 months
  • Lacks telephone access
  • Lacks mailing address or ability to receive study materials electronically
  • Currently being followed in a pediatric clinical setting (either for primary care or for cancer care)
  • History of having had \> 1 cancer type diagnosed and treated (exception is for skin cancers treated with surgical excision alone; also, individuals who only have had relapse of their initial cancer remain eligible so long as they have completed curative therapy and meet all other eligibility criteria)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States

Location

Related Publications (3)

  • Yi JC, Lee E, Duggan C, Baker KS, Blythe N, Cole AM, Cushing-Haugen KL, Gutierrez AI, Linden H, Mendoza JA, Ohlsen TJD, Ortblad KF, Schwartz SM, Yung R, Ceballos R, Chow EJ. Perspective of Hispanic Cancer Survivors on Survivorship Care Plans: A Qualitative Study. J Immigr Minor Health. 2025 Oct 14. doi: 10.1007/s10903-025-01794-8. Online ahead of print.

  • Chow EJ, Blythe NA, Cushing-Haugen KL, Duggan C, Baker KS, Cole AM, Green S, Guiterrez AI, Lee E, Linden HM, Mendoza JA, Ohlsen TJD, Ortblad KF, Schwartz SM, Yung RL, Ceballos RM. Enhancing survivorship care among Hispanic/Latino cancer survivors via lay health educators: results of a pilot randomized trial. J Cancer Surviv. 2025 Feb 15:10.1007/s11764-025-01758-9. doi: 10.1007/s11764-025-01758-9. Online ahead of print.

  • Duggan C, Cushing-Haugen KL, Cole AM, Allen J, Gilles R, Hornecker JR, Gutierrez AI, Warner J, Baker KS, Ceballos RM, Chow EJ. Feasibility of delivering survivorship care via lay health educators: A pilot randomized controlled trial among rural cancer survivors. J Rural Health. 2023 Jun;39(3):666-675. doi: 10.1111/jrh.12736. Epub 2023 Jan 2.

MeSH Terms

Conditions

Breast NeoplasmsColorectal NeoplasmsLung NeoplasmsLymphomaProstatic Neoplasms

Interventions

Early Intervention, EducationalEducational StatusMethodsPalliative Care

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesNeoplasms by Histologic TypeLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesSocioeconomic FactorsPopulation CharacteristicsInvestigative TechniquesPatient CareTherapeutics

Study Officials

  • Eric Chow

    Fred Hutch/University of Washington Cancer Consortium

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
Personnel other than the statisticians and lay health educators
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2019

First Posted

September 9, 2019

Study Start

February 19, 2020

Primary Completion

December 31, 2025

Study Completion

March 31, 2026

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations